Drug
Vh4524184
Vh4524184: highest development phase Phase 2, developed by ViiV Healthcare. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- ViiV Healthcare
Trials
| Drug | Phase | Indication |
|---|---|---|
| VH4524184 NCT07202546 | Phase 2 | HIV Infections |
Latest
No recent events.
Follow Vh4524184 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.